Clinical Study

Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration

Figure 1

Column chart showing the change in mean aqueous VEGF levels (a) and change in mean aqueous IL-6 levels (b) in the study patients. The error bar represents standard deviation.